Management of low-risk papillary thyroid cancer. Minimally-invasive treatments dictate a further paradigm shift?

E Papini; R Guglielmi; R Novizio; A Pontecorvi; C Durante

doi:10.1007/s12020-024-03864-7

Management of low-risk papillary thyroid cancer. Minimally-invasive treatments dictate a further paradigm shift?

Endocrine. 2024 May 20. doi: 10.1007/s12020-024-03864-7. Online ahead of print.

Authors

E Papini¹, R Guglielmi¹, R Novizio², A Pontecorvi², C Durante³

Affiliations

¹ Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Albano, Rome, Italy.
² Department of Endocrinology, Catholic University of The Sacred Heart, Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
³ Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. cosimo.durante@uniroma1.it.

PMID: 38767774
DOI: 10.1007/s12020-024-03864-7

Abstract

Background: Current management options for PTMC include lobo-isthmectomy and active surveillance (AS). Recently, ultrasound-guided minimally invasive procedures (MITs) are offered as a nonsurgical therapy for PTMC because they do not require hospitalization and general anaesthesia, and do not result in loss of thyroid function or cosmetic damage. MITs are reported to consistently provide, mostly in large retrospective series of patients, a rapid, safe, and cost-effective way to eradicate low-risk thyroid malignancies. However, conclusive data from well-conducted prospective studies on the histologically-proven completeness of tumor ablation and the long-term clinical advantages versus AS are still lacking.

Objectives: This study aimed to evaluate the efficacy and safety of ultrasound-guided minimally invasive treatments (MITs) for PTMC in comparison to traditional surgical methods and active surveillance, and to assess their role in current clinical practice.

Methods: A structured literature review was conducted using keywords related to PTMC, MIT, and comparative techniques. Studies were evaluated based on treatment modality, patient selection, follow-up duration, complication rates, and clinical outcomes.

Results: MITs have shown promising results in the management of PTMC. These treatments offer several advantages over surgery, such as reduced use of surgical resources, lower costs, minimal work disruption, and fewer major complications. However, there are still limitations, including the need for long-term surveillance and the potential risk of incomplete tumor ablation.

Conclusions: MITs represent a promising non-surgical option for managing low-risk PTMC, especially for patients ineligible for or refusing surgery. Despite favorable outcomes, more robust prospective data are needed to confirm their long-term benefits and completeness of tumor ablation. Interdisciplinary discussions and thorough patient education on the advantages and limitations of MITs are crucial for informed decision-making.

Keywords: Laser; Microwaves; Minimally invasive procedures; Papillary thyroid cancer; Radiofrequency; Thermal ablation.

Publication types

Review